Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Salih Sertaç Durusoy"'
Autor:
Özgür Mehtap, Tayfur Toptas, Mehmet Sinan Dal, Güner Hayri Özsan, Nigün Sayinalp, Güray Saydam, Mehmet Ali Uçar, Hakki Onur Kirgizlar, Ozan Salim, Atakan Tekinalp, Fahir Özkalemkaş, Funda Pepedil Tanrikulu, Olga Meltem Akay, Emrah Kiliçaslan, Semra Paydas, Sinem Civriz, Mehmet Yilmaz, Volkan Karakuş, Fatma Geçgel, Tahir Darçin, Elçin Erdoğan, Erkin Çinar, Fatma Keklik Karadağ, Ünal Ataş, Vildan Gürsoy, Salih Sertaç Durusoy, Elif Birtaş Ateşoğlu, Anil Tombak, Nurhilal Büyükkurt, Muhit Özcan, Fevzi Altuntaş, Ahmet Burhan Ferhanoğlu
Publikováno v:
HemaSphere, Vol 7, p e566791c (2023)
Externí odkaz:
https://doaj.org/article/e9b3c75689fe4673b443fbabb3a75f21
Autor:
Anıl Tombak, Funda Pepedil Tanrıkulu, Salih Sertaç Durusoy, Hüseyin Derya Dinçyürek, Emin Kaya, Elif Gülsüm Ümit, İrfan Yavaşoğlu, Özgür Mehtap, Burak Deveci, Mehmet Ali Özcan, Hatice Terzi, Müfide Okay, Nilgün Sayınalp, Mehmet Yılmaz, Vahap Okan, Alperen Kızıklı, Ömer Özcan, Güven Çetin, Sinan Demircioğlu, İsmet Aydoğdu, Güray Saydam, Eren Arslan Davulcu, Gül İlhan, Mehmet Ali Uçar, Gülsüm Özet, Seval Akpınar, Burhan Turgut, İlhami Berber, Erdal Kurtoğlu, Mehmet Sönmez, Derya Selim Batur, Rahşan Yıldırım, Vildan Özkocaman, Ahmet Kürşad Güneş, Birsen Sahip, Şehmus Ertop, Olga Meltem Akay, Abdülkadir Baştürk, Mehmet Hilmi Doğu, Aydan Akdeniz, Ali Ünal, Ahmet Seyhanlı, Emel Gürkan, Demet Çekdemir, Burhan Ferhanoğlu
Publikováno v:
Turkish Journal of Hematology, Vol 38, Iss 4, Pp 273-285 (2021)
Objective: This study aimed to retrospectively evaluate the efficacy, safety, and survival outcome of single-agent ibrutinib therapy in chronic lymphocytic leukemia patients. Materials and Methods: A total of 136 patients (mean age +- standard deviat
Externí odkaz:
https://doaj.org/article/506b9a34c2d64dd5beb096f766347808
Autor:
Ilknur Demir, Sacide Pehlivan, Vahap Okan, Handan Haydaroglu Sahin, Salih Sertaç Durusoy, Istemi Serin, Yasemin Oyaci, Mustafa Pehlivan
Publikováno v:
BMC Research Notes, Vol 14, Iss 1, Pp 1-6 (2021)
Abstract Objective Studies on the genetic background of patients with multiple myeloma (MM) have been increasing; two important factors considered in such works are uncoupling protein-2 (UCP-2) and nuclear receptor subfamily 3 group C member 1 (NR3C1
Externí odkaz:
https://doaj.org/article/3b174e6952134cb29e216e612594144e
Autor:
Eren Arslan Davulcu, Zühal Demirci, Umut Yılmaz, Muhlis Cem Ar, Hava Üsküdar Teke, Volkan Karakuş, Rafiye Çiftçiler, Cem Selim, İrfan Yavaşoğlu, Salih Sertaç Durusoy, Vahap Okan, Aydan Akdeniz, Alkım Yolcu, İsmet Aydoğdu, Tekin Güney, Asu Fergün Yılmaz, Fahri Şahin
Acquired hemophilia A (AHA) is a rare disease caused by autoantibodies inhibiting factor VIII (FVIII) activity. Although the conditionis usually idiopathic, there may be other underlying diseases. Treatment consists of two steps: treatment of acute b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::744f6e5495a4b4fba10e552e50e10563
https://hdl.handle.net/11454/76288
https://hdl.handle.net/11454/76288
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 44, Iss , Pp S32- (2022)
Objective: Mantle cell lymphoma (MCL) is an agressive B-cell lymphoma, constitutes 3-10% of all non-Hodgkin's lymphomas. MCL usually presents with generalized lymph node involvement. The prognosis is poor and incurable. Extranodal involvement is not
Externí odkaz:
https://doaj.org/article/5a4ffbbf744741f990f0637d343998be